| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |